Get started
REBUS HLDGS INC.REBUS HLDGS INC.REBUS HLDGS INC.

REBUS HLDGS INC.

No trades
See on Supercharts
Overview
Financials News Ideas Technicals

RBSH chart

Upcoming earnings

Next report date
Report period
Q1 2024
EPS estimate
—
Revenue estimate
—

Key stats

Market capitalization
‪3.21 K‬USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
—
Net income (FY)
‪−1.02 M‬USD
Revenue (FY)
—
Shares float
‪32.13 M‬
Beta (1Y)
2.01

About REBUS HLDGS INC.

Sector
Health Technology
Industry
Biotechnology
CEO
Silvestre Raul
Website
inspyrtherapeutics.com
Headquarters
Westlake Village
Employees (FY)
1
Founded
2003
FIGI
BBG000PBSB93
Rebus Holdings, Inc. is a pharmaceutical company engaged in the research and development of novel therapeutics for the treatment of cancer. Its product pipeline includes Mipsagargin, a dual A2A/A2B antagonist, an A2A antagonist, an A2B antagonist, and an A2A agonist. The company was founded by Craig A. Dionne, John T. Issacs, and Samuel R. Denmeade on November 21, 2003 and is headquartered in Westlake Village, CA.

Financials

Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

News

Keep reading

Technicals

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Stock brokers

Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of RBSH is 0.000100 USD — it hasn't changed in the past 24 hours. Watch REBUS HLDGS INC. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange REBUS HLDGS INC. stocks are traded under the ticker RBSH.
REBUS HLDGS INC. is going to release the next earnings report on May 10, 2024. Keep track of upcoming events with our Earnings Calendar.
RBSH stock is 0% volatile and has beta coefficient of 2.01. Track REBUS HLDGS INC. stock price on the chart and check out the list of the most volatile stocks — is REBUS HLDGS INC. there?
Yes, you can track REBUS HLDGS INC. financials in yearly and quarterly reports right on TradingView.
No, RBSH doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, RBSH shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade REBUS HLDGS INC. stock right from TradingView charts — choose your broker and connect to your account.
RBSH reached its all-time high on Feb 13, 2019 with the price of 22099.153577 USD, and its all-time low was 0.000100 USD and was reached on Mar 14, 2024. View more price dynamics on RBSH chart.
See other stocks reaching their highest and lowest prices.
As of May 4, 2024, the company has 1.00 employees. See our rating of the largest employees — is REBUS HLDGS INC. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So REBUS HLDGS INC. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating REBUS HLDGS INC. stock shows the sell signal. See more of REBUS HLDGS INC. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.